Search Azmacare.com
Popular Asthma Articles
Eclectic Institute Compound Herbal Elixir
By Cody Wells on December 27, 2009
Compound Herbal Elixir produced by the Eclectic Institute is recommended and used widely as a cough and asthma treatment by physicians and naturopaths worldwide.
I first heard about this herbal compound from an article I read entitled “Notes on the Herbal Treatment of Asthma.” I was researching white pine bark for an update to my “OPC [...]
Posted in Asthma Treatment & Management | Tagged chinese herbs, chinese medicine, grape seed extract, herbal extract, herbal medicine, herbal remedy, lung health, opc antioxidant, respiratory system | Leave a response
Long-term Controller Asthma Medications
By Cody Wells on November 21, 2009
Long-term-controller asthma medications or simply controller asthma medications are designed for you to take on a daily basis to control your persistent asthma.
Posted in Asthma Medications | Tagged action plan, anti-leukotrienes, asthma action plan, asthma attacks, asthma episode, asthma inhaler, beta2 adrenergic agonist, bronchodilators, corticosteroid, fda, food and drug administration, inhaled corticosteroids, laba, leukotriene modifiers, oral bronchodilator, public health advisory | Leave a response
Quick-Relief Asthma Medications
By Cody Wells on November 19, 2009
Quick relief asthma medications are also called rescue medications. They are designed to keep you alive by providing quick relief during an acute asthma attack (episode). They are called short-acting bronchodilators, because they quickly open up your airways, which makes it easier for you to breathe. Quick-relief asthma medications can be separated into [...]
Posted in Asthma Medications | Tagged action plan, acute asthma attack, anticholinergic, asthma action plan, asthma attacks, asthma episode, asthma inhaler, beta adrenergic agonist, beta2 adrenergic agonist, breathing problem, bronchodilators, corticosteroid, epa, inhaled steroids, intravenous corticosteroid, oral corticosteroid, respiratory distress | Leave a response
